Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout

Immunodeficient mice are widely used for pre-clinical studies to understand various human diseases. Here, we report the generation of four immunodeficient mouse models using CRISPR/Cas9 system without inserting any foreign gene sequences such as Neo R cassettes and their characterization. By elimina...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transgenic research 2018-06, Vol.27 (3), p.241-251
Hauptverfasser: Lee, Jae Hoon, Park, Jong-Hyung, Nam, Tae-Wook, Seo, Sun-Min, Kim, Jun-Young, Lee, Han-Kyul, Han, Jong Hyun, Park, Song Yi, Choi, Yang-Kyu, Lee, Han-Woong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Immunodeficient mice are widely used for pre-clinical studies to understand various human diseases. Here, we report the generation of four immunodeficient mouse models using CRISPR/Cas9 system without inserting any foreign gene sequences such as Neo R cassettes and their characterization. By eliminating any possible effects of adding a Neo R cassette, our mouse models may allow us to better elucidate the in vivo functions of each gene. Our FVB- Rag2 −/− , B6- Rag2 −/− , and BALB/c- Prkdc −/− mice showed phenotypes similar to those of the earlier immunodeficient mouse models, including a lack of mature B cells and T cells and an increase in the number of CD45 + DX-5 + natural killer cells. However, B6- Il2rg −/− mice had a unique phenotype, with a lack of mature B cells, increased number of T cells, and decreased number of natural killer cells. Additionally, serum immunoglobulin levels in all four immunodeficient mouse models were significantly reduced when compared to those in wild-type mice with the exception of IgM in B6- Il2r g −/− mice. These results indicate that our immunodeficient mouse models are a robust tool for in vivo studies of the immune system and will provide new insights into the variation in phenotypic outcomes resulting from different gene-targeting methodologies.
ISSN:0962-8819
1573-9368
DOI:10.1007/s11248-018-0069-y